Transketolase (TKT) Peptid
TKT
Reaktivität: Human
Wirt: Synthetic
BP, IHC, WB
Produktnummer ABIN985121
Kurzübersicht für Transketolase (TKT) Peptid (ABIN985121)
Target
TKT
(Transketolase (TKT))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
-
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-TKT antibody (Catalog #: ARP48540_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- TKT (Transketolase (TKT))
-
Hintergrund
-
TKT belongs to the transketolase family. TKT has been implicated in the latent genetic disease Wernicke-Korsakoff syndrome (WKS), which causes specific brain damage.
Alias Symbols: FLJ34765, TKT1, TK
Protein Interaction Partner: MYOC,TKT,TKT
Protein Size: 623 -
Molekulargewicht
- 68 kDa
-
Gen-ID
- 7086
-
NCBI Accession
- NM_001064, NP_001055
-
UniProt
- P29401
Target
-
Sie sind hier:
